Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert E. Bellet
Robert E. Bellet
Medicine
Pathology
Diabetes mellitus
Neutropenia
Cancer
4
Papers
418
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin ® , in resistant solid tumor malignancies
2009
Cancer Chemotherapy and Pharmacology
Paula M. Fracasso
Joel Picus
Jonathan Wildi
Sherry A. Goodner
Allison N. Creekmore
Feng Gao
Ramaswamy Govindan
Matthew J. Ellis
Benjamin R. Tan
Gerald P. Linette
ChauHwei J. Fu
Helen S. Pentikis
Stephen C. Zumbrun
Merrill J. Egorin
Robert E. Bellet
Show All
Source
Cite
Save
Citations (38)
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
1995
Journal of Clinical Oncology
Vicente Valero
Frankie A. Holmes
Ronald S. Walters
Richard L. Theriault
Laura Esparza
Giuseppe Fraschini
Gustavo A. Fonseca
Robert E. Bellet
Aman U. Buzdar
Gabriel N. Hortobagyi
Show All
Source
Cite
Save
Citations (358)
Cryptococcal pleural effusion.
1975
JAMA
Jerry D. Smilack
Robert E. Bellet
William T. Talman
Show All
Source
Cite
Save
Citations (11)
Estrogen-induced hypernephroma.
1974
The Journal of Urology
Robert E. Bellet
Alfonse P. Squitieri
Show All
Source
Cite
Save
Citations (11)
1